Article Information
History
- April 19, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Laura M. Jacobsen1,*,
- Jennifer L. Sherr2,*,
- Elizabeth Considine2,
- Angela Chen1,
- Sarah Peeling1,
- Margo Hulsmans3,
- Sara Charleer3,
- Marzhan Urazbayeva4,
- Mustafa Tosur4,5,
- Selma Alamarie6,
- Maria J. Redondo4,
- Korey K. Hood6,
- Peter A. Gottlieb7,
- Pieter Gillard3,
- Jessie J. Wong5,
- Irl B. Hirsch8,
- Richard E. Pratley9,
- Lori Laffel10,**,
- Chantal Mathieu3,#,** and
- ADA/EASD Precision Medicine in Diabetes Initiative Consortium
- 1University of Florida, Gainesville, FL, USA
- 2Yale School of Medicine, New Haven, CT, USA
- 3University Hospital Leuven, Leuven, Belgium
- 4Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, USA
- 5Children’s Nutrition Research Center, USDA/ARS, Houston, TX, USA
- 6Stanford University School of Medicine, Stanford, CA, USA
- 7Barbara Davis Center, University of Colorado School of Medicine, Aurora, CO, USA
- 8University of Washington School of Medicine, Seattle, WA, USA
- 9AdventHealth Translational Research Institute, Orlando, FL, USA
- 10Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA
- ↵#Corresponding Author
: Chantal Mathieu, Department of Endocrinology, University Hospital Leuven, Leuven, Belgium, chantal.mathieu{at}uzleuven.be.
Posted April 19, 2023.
Utility of Technology in the Treatment of Type 1 Diabetes: Current State of the Art and Precision Evidence
